1. 932PHyperphosphatemia due to erdafitinib (a pan-FGFR Inhibitor) and anti-tumour activity among patients (Pts) with advanced urothelial carcinoma (UC). (1st October 2019) Authors: Tagawa, S; Siefker-Radtke, A; Dosne, A -G; Zhong, B; Qi, K; Shalaby, W; O'Hagan, A; De Porre, P; Mahadevia, P; Loriot, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗